2025 A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm Group Chronic Malignancies Working Party (CMWP) 1st listed author Alexandros Rampotas Journal Bone Marrow Transplant.
2025 Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT Group Transplant Complications Working Party (TCWP) 1st listed author Ivan Moiseev Journal Bone Marrow Transplant.
2025 Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working Party Group Transplant Complications Working Party (TCWP) 1st listed author Agnieszka Tomaszewska Journal Cancers (Basel).
2025 Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition Group Cellular Therapy & Immunobiology Working Party (CTIWP) GoCART Coalition Other society 1st listed author Ganesh Ramesh Journal Bone Marrow Transplant.
2025 Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jan Vydra Journal Bone Marrow Transplant.
2025 Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWP Group Acute Leukemia Working Party (ALWP) 1st listed author Ali Bazarbachi Journal Bone Marrow Transplant.
2025 Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee Group Lymphoma Working Party (LWP) Practice Harmonisation and Guidelines Committee 1st listed author Gandhi Damaj Journal Bone Marrow Transplant.
2025 Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival - an EBMT PDWP retrospective study Group Paediatric Diseases Working Party (PDWP) 1st listed author A Bertaina Journal Bone Marrow Transplant.
2025 Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia Group Infectious Diseases Working Party (IDWP) 1st listed author Dina Averbuch Journal Lancet Infect Dis.
2025 Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) 1st listed author Marta Villalba Journal Bone Marrow Transplant.
2025 Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines Committee Group Practice Harmonisation and Guidelines Committee 1st listed author Giorgia Battipaglia Journal Bone Marrow Transplant.
2025 Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jaime Sanz Journal Bone Marrow Transplant.